OmniAb, Inc.
For the period ended Sep 30, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 4, 2025
OABI$5.10-3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities: | ||
| Net loss | $(50,600) | $(48,965) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 14,047 | 15,977 |
| Share-based compensation | 12,218 | 16,383 |
| Amortization of discounts on short-term investments, net | (614) | (1,285) |
| Deferred income taxes, net | (1,148) | (7,223) |
| Change in estimated fair value of contingent liabilities | 201 | (2,410) |
| Gain on sale of ion channel asset | (3,000) | — |
| Other | 153 | 524 |
| Changes in operating assets and liabilities, net: | ||
| Accounts receivable, net | 2,369 | 1,263 |
| Prepaid expenses and other current assets | (322) | 341 |
| Other long-term assets | 512 | 564 |
| Accounts payable, accrued expenses, and other liabilities | (1,491) | (3,186) |
| Operating lease liabilities | (2,095) | (1,722) |
| Deferred revenue | (1,011) | (6,053) |
| Net cash used in operating activities | (30,781) | (35,792) |
| Investing activities: | ||
| Purchases of short-term investments | (38,578) | (25,669) |
| Proceeds from the maturity of short-term investments | 39,800 | 63,500 |
| Purchases of property and equipment | (556) | (1,829) |
| Payment of contingent liabilities | — | (400) |
| Proceeds from sale of short-term investments | 90 | 1,897 |
| Proceeds from sale of ion channel asset | 3,000 | — |
| Net cash provided by investing activities | 3,756 | 37,499 |
| Financing activities: | ||
| Payment of contingent liabilities | (450) | (75) |
| Proceeds from issuance of common stock from stock plans | 341 | 2,251 |
| Taxes paid related to net share settlement of equity awards | — | (960) |
| Proceeds from issuance of common stock in private placement, net of commissions | 28,199 | — |
| Proceeds from issuance of common stock under ATM facility, net of commissions | — | 8,480 |
| Payment of transaction costs | (126) | (525) |
| Net cash provided by financing activities | 27,964 | 9,171 |
| Net change in cash, cash equivalents and restricted cash | 939 | 10,878 |
| Cash, cash equivalents and restricted cash at beginning of period | 28,158 | 16,918 |
| Cash, cash equivalents and restricted cash at end of period | $29,097 | $27,796 |
| Supplemental cash flow information: | ||
| Deferred revenue recorded in accounts receivable | $192 | $892 |
| Supplemental non-cash investing and financing activities: | ||
| Transaction costs recorded in accounts payable and other current liabilities | 198 | 30 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.